Severe lithium toxicity associated with indapamide therapy. 1990

M E Hanna, and C B Lobao, and J T Stewart

UI MeSH Term Description Entries
D007190 Indapamide A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS. Metindamide,S-1520,SE-1520,S 1520,S1520,SE 1520,SE1520
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D016651 Lithium Carbonate A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. CP-15,467-61,Dilithium Carbonate,Eskalith,Lithane,Lithium Bicarbonate,Lithobid,Lithonate,Lithotabs,Micalith,NSC-16895,Priadel,Quilinorm-retard,Bicarbonate, Lithium,CP 15,467 61,CP15,46761,Carbonate, Dilithium,Carbonate, Lithium,NSC 16895,NSC16895,Quilinorm retard,Quilinormretard

Related Publications

M E Hanna, and C B Lobao, and J T Stewart
December 1982, Ugeskrift for laeger,
M E Hanna, and C B Lobao, and J T Stewart
January 1993, Therapie,
M E Hanna, and C B Lobao, and J T Stewart
January 2005, The Annals of pharmacotherapy,
M E Hanna, and C B Lobao, and J T Stewart
April 1992, Archives of ophthalmology (Chicago, Ill. : 1960),
M E Hanna, and C B Lobao, and J T Stewart
July 2011, Current drug safety,
M E Hanna, and C B Lobao, and J T Stewart
April 1978, British medical journal,
M E Hanna, and C B Lobao, and J T Stewart
December 1972, Lancet (London, England),
M E Hanna, and C B Lobao, and J T Stewart
March 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
M E Hanna, and C B Lobao, and J T Stewart
May 1992, Annals of internal medicine,
M E Hanna, and C B Lobao, and J T Stewart
November 1991, Journal of neurology, neurosurgery, and psychiatry,
Copied contents to your clipboard!